[Federal Register Volume 70, Number 63 (Monday, April 4, 2005)]
[Notices]
[Pages 17094-17095]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-6534]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifier: CMS-10008]


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

AGENCY: Centers for Medicare & Medicaid Services, HHS.
    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid 
Services (CMS), Department of Health and Human Services, is publishing 
the following summary of proposed collections for public comment. 
Interested persons are invited to send comments regarding this burden 
estimate or any other aspect of this collection of information, 
including any of the following subjects: (1) The necessity and utility 
of the proposed information collection for the proper performance of 
the Agency's function; (2) the accuracy of the estimated burden; (3) 
ways to enhance the quality, utility, and clarity of the information to 
be collected; and (4) the use of automated collection techniques or 
other forms of information technology to minimize the information 
collection burden.
    1. Type of Information Collection: Revision of a currently approved 
collection; Title of Information Collection: Process and Information 
Required to Determine Eligibility of Drugs, Biologicals, and Radio-
pharmaceutical Agents for Transitional Pass-Through Provisions Under 
the Hospital Outpatient Prospective Payment System (OPPS) and 
Supporting Regulations in 42 CFR, Section 419.43; Use: Section 
1833(t)(6) of the Social Security Act provides for temporary additional 
payments or ``transitional pass-through payments'' for certain drugs 
and biological agents. Interested parties such as hospitals, 
pharmaceutical companies, and physicians can apply for transitional 
pass-through payment for drugs and biologicals used with services 
covered under the OPPS. CMS uses this information to determine if the 
criteria for making a transitional pass-through payment are met and if 
an interim HCPCS code for a new drug or biological is necessary. The 
revisions made to this collection include the addition of Section 303 
of the MMA. This new section establishes the use of the average sales 
price (ASP) methodology for payment; Form Number: CMS-10008 
(OMB 0938-0802); Frequency: On occasion; Affected Public: 
Business or other for-profit and Not-for-profit institutions; Number of 
Respondents: 58; Total Annual Responses: 58; Total Annual Hours: 203.
    To obtain copies of the supporting statement and any related forms 
for the proposed paperwork collections referenced above, access CMS Web 
site address at http://www.cms.hhs.gov/regulations/pra/, or e-mail your 
request, including your address, phone number, OMB number, and CMS 
document identifier, to [email protected], or call the Reports 
Clearance Office on (410) 786-1326.
    Written comments and recommendations for the proposed information 
collections must be mailed within 30 days of this notice directly to 
the OMB desk officer: OMB Human

[[Page 17095]]

Resources and Housing Branch, Attention: Christopher Martin, New 
Executive Office Building, Room 10235, Washington, DC 20503.

    Dated: March 24, 2005.
John P. Burke, III,
CMS Paperwork Reduction Act Reports Clearance Officer, Office of 
Strategic Operations and Regulatory Affairs, Regulations Development 
Group.
[FR Doc. 05-6534 Filed 4-1-05; 8:45 am]
BILLING CODE 4120-01-P